Profiling Exosomal Metabolomics as a Means for Diagnosis and Researching Early-Stage Hypertensive Nephropathy
British Journal of Hospital Medicine · 2025
DOI: 10.12968/hmed.2024.0568 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von Wei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Chengdu Medical College, Nuclear Industry 416 Hospital, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Metabolomics, Exosomes, Hypertension, Renal, Hypertension. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Aims/Background Hypertension (HT) is a prevalent medical condition showing an increasing incidence rate in various populations over recent years. Long-term hypertension increases the risk of the occurrence of hypertensive nephropathy (HTN), which is also a health-threatening disorder. Given that very little is known about the pathogenesis of HTN, this study was designed to identify disease biomarkers, which enable early diagnosis of the disease, through the utilization of high-throughput untargeted metabolomics strategies.
Methods
The participants of this study were patients admitted to The Second Affiliated Hospital of Chengdu Medical College, Nuclear Industry 416 Hospital, who were randomly divided into three groups: Normal group (n = 11), HT group (n = 10), and HTN group (n = 12). Urine exosomes were extracted, purified, and subjected to untargeted metabolomics analysis. Differential metabolites and their significantly enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were identified. The least absolute shrinkage and selection operator (LASSO) regression analysis was then employed to establish a diagnostic model for early-stage HTN. Finally, logistic regression and receiver operating characteristic (ROC) curve analysis were performed to identify biomarkers related to early HTN.
Results
Orthogonal partial least squares-discriminant analysis (OPLS-DA) revealed significant differences in the metabolic profiles of the three patient groups. Compared to subjects of the Normal group, the HT and HTN groups exhibited significantly upregulated and downregulated profiles of differential metabolites, respectively. LASSO regression analysis results indicated that 4-hydroxyphenylacetic acid, bilirubin, uracil, and iminodiacetic acid are potential biomarkers for HTN or HT.
Conclusion
With untargeted metabolomics analysis, we successfully identified differential metabolites in HTN. A further LASSO regression analysis revealed that four key metabolites, namely 4-hydroxyphenylacetic acid, bilirubin, uracil, and iminodiacetic acid, hold promise for the diagnosis of early-stage HTN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Chengdu Medical College, Nuclear Industry 416 Hospital, Chengdu, Sichuan, China.
Zitieren
APA
Chen, W., Jia, M., Yin, R., Zhang, C., He, J., Yang, H., & Wu, Q. (2025). Profiling Exosomal Metabolomics as a Means for Diagnosis and Researching Early-Stage Hypertensive Nephropathy. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0568
Vancouver
Chen W, Jia M, Yin R, Zhang C, He J, Yang H, et al. Profiling Exosomal Metabolomics as a Means for Diagnosis and Researching Early-Stage Hypertensive Nephropathy. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2024.0568
BibTeX
@article{Chen2025,
author = {Chen, Wei and Jia, Meng and Yin, Rui and Zhang, Chengwei and He, Jinchen and Yang, Hong and Wu, Qi},
title = {Profiling Exosomal Metabolomics as a Means for Diagnosis and Researching Early-Stage Hypertensive Nephropathy},
journal = {British Journal of Hospital Medicine},
year = {2025},
doi = {10.12968/hmed.2024.0568}
}
EUVIMED